NCT03642262View on ClinicalTrials.gov

Mucinex® ER 600 mg Bi-layer Tablet Versus Guaifenesin Immediate Release (IR) 200 mg q4h

PHASE1CompletedINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

June 2, 2013

Primary Completion Date

August 9, 2013

Study Completion Date

August 9, 2013

Conditions
Healthy Subjects
Interventions
DRUG

Mucinex®

Mucinex® 600 mg single dose ER bi-layer tablet

All Listed Sponsors
lead

Reckitt Benckiser Inc.

INDUSTRY

NCT03642262 - Mucinex® ER 600 mg Bi-layer Tablet Versus Guaifenesin Immediate Release (IR) 200 mg q4h | Biotech Hunter | Biotech Hunter